| 摘要 |
A method and composition for optimizing immune activity in the treatment of chronic immune conditions wherein the chronic immune conditions is Hepatitis-C. A method and composition is described for reducing the inflammation and the viral activity in the hepatocytes in living mammals, and for reducing the number of carcinogenic free radicals including hydroxyl and super oxide anions in living mammals, and for enhancing the immune system in HIV/Aids infected individuals by enhancing the bodily mechanisms including intracellular communication, gene regulation, gene repair and membrane effects. A method and composition for optimizing immune activity under conditions of chronic immune conditions in the treatment of such chronic immune conditions wherein the chronic immune conditions include Hepatitis-C, Cancer, AIDS/HIV, Herpes, Colds, Influenza, Bronchitis, Chronic fatigue and Epstein Barr. The term Chronic Immune Conditions is defined to include the following diseases, namely Cancer, AIDS/HIV, Hepatitis-C, Herpes, Colds, Influenza, Bronchitis, Chronic fatigue and Epstein Barr. A method and composition for optimizing immune activity, which comprises administering to the mammal a safe and effective daily maximum amount of a mixture of: a) inositol hexaphosphate or a physiologically acceptable salt thereof; b) inositol or a physiologically acceptable salt thereof; c) N-Acetyl Cysteine; d) Alpha Lipoic Acid; and e) a combination of beta-sitosterol and beta-sitosterolin, in the ratio of weight in milligrams of (a):(b):(c):(d), (e) from about 8000 to 10000 milligrams of (a), from about 80 to 250 milligrams of (b), from about 200 to 1500 milligrams of (c), from about 50 to 300 milligrams of (d), and from 5 to 50 milligrams of (e).
|
